Use of proteomics for the identification of novel drug targets in brain diseases

Jose A. Morón, Lakshmi A. Devi

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


In spite of the rapid advances in the development of the new proteomic technologies, there are, to date, relatively fewer studies aiming to explore the neuronal proteome. One of the reasons is the complexity of the brain, which presents high cellular heterogeneity and a unique subcellular compartmentalization. Therefore, tissue fractionation of the brain to enrich proteins of interest will reduce the complexity of the proteomics approach leading to the production of manageable and meaningful results. In this review, general considerations and strategies of proteomics, the advantages and challenges to exploring the neuronal proteome are described and summarized. In addition, this article presents an overview of recent advances of proteomic technologies and shows that proteomics can serve as a valuable tool to globally explore the changes in brain proteome during various disease states. Understanding the molecular basis of brain function will be extremely useful in identifying novel targets for the treatment of brain diseases.

Original languageEnglish
Pages (from-to)306-315
Number of pages10
JournalJournal of Neurochemistry
Issue number2
StatePublished - Jul 2007


  • Brain
  • Brain disease
  • Protein profiling
  • Proteomics
  • Quantitative proteomics
  • Subcellular fractionation


Dive into the research topics of 'Use of proteomics for the identification of novel drug targets in brain diseases'. Together they form a unique fingerprint.

Cite this